Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,083,107
  • Shares Outstanding, K 56,896
  • Annual Sales, $ 2,364 M
  • Annual Income, $ 238,620 K
  • 60-Month Beta 1.05
  • Price/Sales 4.27
  • Price/Cash Flow 10.47
  • Price/Book 2.66
Trade JAZZ with:

Options Overview

Details
  • Implied Volatility 29.21%
  • Historical Volatility 18.69%
  • IV Percentile 3%
  • IV Rank 10.57%
  • IV High 53.77% on 10/30/20
  • IV Low 26.31% on 06/16/21
  • Put/Call Vol Ratio 0.10
  • Today's Volume 285
  • Volume Avg (30-Day) 573
  • Put/Call OI Ratio 1.24
  • Today's Open Interest 28,146
  • Open Int (30-Day) 43,441

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 3.48
  • Number of Estimates 5
  • High Estimate 3.89
  • Low Estimate 2.99
  • Prior Year 3.26
  • Growth Rate Est. (year over year) +6.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.09 +3.63%
on 06/03/21
189.00 -6.19%
on 06/15/21
-2.70 (-1.50%)
since 05/21/21
3-Month
159.02 +11.50%
on 04/09/21
189.00 -6.19%
on 06/15/21
+6.71 (+3.93%)
since 03/22/21
52-Week
103.46 +71.38%
on 07/09/20
189.00 -6.19%
on 06/15/21
+64.47 (+57.14%)
since 06/22/20

Most Recent Stories

More News
3 Top Biotech Stocks To Bolster Your Portfolio

Illumina (ILMN), Jazz Pharmaceuticals (JAZZ), and Amgen (AMGN) are 3 of the top biotech stocks. The sector has been an underperformer over the last few years but could start outperforming given the aging...

AMGN : 239.91 (-0.14%)
JAZZ : 177.30 (+0.05%)
ILMN : 465.69 (+1.01%)
New Strong Sell Stocks for June 22nd

ABT, BNL, ITRG, JAZZ, and MANU have been added to the Zacks Rank #5 (Strong Sell) List on June 22, 2021

ABT : 110.96 (-0.43%)
JAZZ : 177.30 (+0.05%)
MANU : 15.41 (-0.58%)
ITRG : 2.95 (+1.72%)
BNL : 23.72 (-4.89%)
Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plc

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today updated its full year 2021 financial guidance to incorporate the GW Pharmaceuticals (GW) business, which the Company acquired on May 5, 2021....

JAZZ : 177.30 (+0.05%)
Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer Community

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the launch of Nothing Small About It (), an online program developed with consultation from leading cancer organizations CancerGO2...

JAZZ : 177.30 (+0.05%)
Jazz Pharmaceuticals Presents 18 Abstracts in Sleep Medicine at SLEEP 2021

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from investigator-sponsored trials will be presented at SLEEP...

JAZZ : 177.30 (+0.05%)
Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030

Reportlinker.com announces the release of the report "Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030" - https://www.reportlinker.com/p06090627/?utm_source=GNW

DVAX : 8.95 (-3.35%)
IONS : 37.69 (+2.11%)
JAZZ : 177.30 (+0.05%)
MRK : 76.19 (-0.73%)
MGEN : 23.01 (-0.09%)
SRPT : 79.60 (+1.02%)
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

PALM BEACH,  Fla., /PRNewswire/ --  The recent pandemic has, as we all know, negatively affected almost every business and financial markets across the globe… and even the seemingly ever increasing...

RTSL : 0.6000 (unch)
JAZZ : 177.30 (+0.05%)
NTEC : 3.87 (-6.07%)
CARA : 13.89 (-3.14%)
ARNA : 66.88 (-1.85%)
NASDAQ Manages to Advance in Slow Start to the Week

NASDAQ Manages to Advance in Slow Start to the Week

JAZZ : 177.30 (+0.05%)
MRNA : 221.36 (+6.30%)
EQIX : 822.57 (+0.01%)
BLMN : 26.25 (-0.34%)
BERY : 64.59 (+0.58%)
SBH : 22.08 (+13.58%)
ANF : 42.64 (+2.75%)
DKS : 97.01 (+1.14%)
TGT : 237.21 (+1.47%)
CNR : 18.06 (+0.06%)
MGNI : 31.52 (+4.34%)
BIGC : 63.93 (-1.45%)
Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of GW Pharmaceuticals, PLC In The Southern District Of California

, /PRNewswire/ -- Notice is hereby given that has filed a class action lawsuit in District Court for the Southern District of , , Docket No. 3:21-cv-01019, on behalf of holders of American Depositary...

JAZZ : 177.30 (+0.05%)
GWPRF : 17.0000 (+16.92%)
GWPH : 218.96 (-0.15%)
BIOTECanada Board Announces Addition of Directors and New Chair

The BIOTECanada Board of Directors is pleased to announce the election of Gordon C. McCauley, President and CEO, AdMare BioInnovations, as Chairman of BIOTECanada at today's Annual General Meeting. Mr....

JAZZ : 177.30 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and...

See More

Key Turning Points

3rd Resistance Point 183.16
2nd Resistance Point 181.00
1st Resistance Point 179.15
Last Price 177.30
1st Support Level 175.14
2nd Support Level 172.98
3rd Support Level 171.13

See More

52-Week High 189.00
Last Price 177.30
Fibonacci 61.8% 156.32
Fibonacci 50% 146.23
Fibonacci 38.2% 136.13
52-Week Low 103.46

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar